Skip to main content

Table 1 Demographics and clinical characteristics of the patients based upon ICU mortality

From: Early natural killer cell counts in blood predict mortality in severe sepsis

Demographic and clinical characteristics

Survivors

(n= 29)

Nonsurvivors

(n= 21)

Total population

(n= 50)

Survivors vs nonsurvivors

P value

Age (years)

66.0 (20.0)

72.0 (14)

68.5 (19.2)

0.048

Males

18 (62%)

14 (66.6%)

32 (64%)

n.s.

APACHE II score at ICU admission

18.0 (15.0)

23.0 (10.0)

20.5 (13.2)

n.s.

SOFA score at ICU admission

7.0 (6.0)

9.0 (2.0)

8.0 (4.0)

n.s.

Comorbidities

    

   Cardiovascular disease

8 (26.6%)

7 (35%)

15 (30%)

n.s.

   COPD

2 (6.6%)

6 (30%)

8 (16%)

0.025

   Chronic renal failure or dialysis

2 (6.6%)

2 (10%)

4 (8%)

n.s.

   Diabetes mellitus types 1 and 2

10 (33.3%)

7 (35%)

17 (34%)

n.s.

   Alcohol abuse

2 (6.6%)

1 (5%)

3 (6%)

n.s.

   Hypertension

12 (41.3%)

7 (33.3%)

19 (38%)

n.s.

   Neoplasia

3 (10%)

5 (25%)

8 (16%)

n.s.

   Obesity

2 (6.6%)

1 (5%)

3 (6%)

n.s.

Diagnostic at ICU admission

    

   Severe sepsis

11 (36.6%)

1 (5%)

12 (24%)

0.007

   Septic shock

18 (62%)

20 (95.2%)

38 (76%)

0.007

Presumed source of infection

    

   Lower respiratory tract/pneumonia

14 (46.6%)

9 (45%)

23 (46%)

n.s.

   Urogenital

6 (20%)

3 (15%)

9 (18%)

n.s.

   Intra-abdominal

2 (6.6%)

3 (15%)

5 (10%)

n.s.

   Catheter- or device-related

1 (3.3%)

1 (5%)

2 (4%)

n.s.

   Skin (soft tissues)

2 (6.6%)

1 (5%)

3 (6%)

n.s.

   Prosthesis

2 (6.6%)

0 (0%)

2 (4%)

n.s.

   Central nervous system

1 (3.3%)

0 (0%)

1 (2%)

n.s.

   Other/unknown

2 (6.8%)

4 (19%)

6 (12%)

n.s.

Documented microbial agent

    

   Gram-positive

8 (26%)

6 (30%)

14 (28%)

n.s.

   Gram-negative

10 (34.4%)

9 (42.8%)

19 (38%)

n.s.

   Fungi

2 (6.6%)

1(5%)

3 (6%)

n.s.

  1. Continuous variables are expressed as medians (IQR). All other data are raw numbers (%). Proportions were compared using the Χ2 test or Fisher's exact test where appropriate. APACHE II: Acute Physiology and Chronic Health Evaluation II; COPD: chronic obstructive pulmonary disease; SOFA: sequential organ failure assessment score; n.s. = not significant.